ConductScience.org, home

Paper39479216

NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection.

Chambon M and 1 other. Transpl Int, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection. Papers, record 39479216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39479216

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection.
PubMed
Journal
Transpl Int
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.08, provisional
iCite
Revised in PubMed
2025-07-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chambon MMathilde
2Koenig AAlice

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
Graft RejectionMajor topic
Humans
Chronic Disease
Animals
Graft Survival

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07718308CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant RecipientsResults

Source ClinicalTrials.gov

Download CSV of trials

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137220805
Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
Kidney Int2023https://conductscience.org/library/papers/37220805PubMed
211466332IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.J Immunol2001https://conductscience.org/library/papers/11466332PubMed
39396765Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity.J Exp Med1997https://conductscience.org/library/papers/9396765PubMed
422070565A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.Am J Transplant2012https://conductscience.org/library/papers/22070565PubMed
532641395Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.J Am Soc Nephrol2020https://conductscience.org/library/papers/32641395PubMed
631767837Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.Nat Commun2019https://conductscience.org/library/papers/31767837PubMed
720973913Long-term renal allograft survival in the United States: a critical reappraisal.Am J Transplant2011https://conductscience.org/library/papers/20973913PubMed
836066491Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression.J Exp Med2022https://conductscience.org/library/papers/36066491PubMed
919843029Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.Am J Transplant2009https://conductscience.org/library/papers/19843029PubMed
1022105371CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.Eur J Immunol2012https://conductscience.org/library/papers/22105371PubMed
1118523245The innate NK cells, allograft rejection, and a key role for IL-15.J Immunol2008https://conductscience.org/library/papers/18523245PubMed
127541798Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells.J Biol Chem1995https://conductscience.org/library/papers/7541798PubMed
1321883901Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.Am J Transplant2011https://conductscience.org/library/papers/21883901PubMed
1426555944One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.Transplantation2016https://conductscience.org/library/papers/26555944PubMed
1519392983Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.Am J Transplant2009https://conductscience.org/library/papers/19392983PubMed
1633239394Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection.J Am Soc Nephrol2021https://conductscience.org/library/papers/33239394PubMed
1729478298Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation.Am J Transplant2018https://conductscience.org/library/papers/29478298PubMed
1820659089NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.Am J Transplant2010https://conductscience.org/library/papers/20659089PubMed
1930396694Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.Kidney Int2019https://conductscience.org/library/papers/30396694PubMed
208675682Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.J Clin Invest1996https://conductscience.org/library/papers/8675682PubMed

See all 70 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42587776Platelet-Derived Exosome Product Prolongs Stem Cell-Derived β-Cell Graft Survival and Is Associated with Reduced Nk Cell Infiltration and Immunomodulation.Cells2026https://conductscience.org/library/papers/42587776PubMed
42382225Not all antibodies are created equal: total IgG glycosylation and severity of antibody-mediated rejection in kidney transplantation.Transpl Int2026https://conductscience.org/library/papers/42382225PubMed
42201030Unsupervised Immune Profiling Identifies Distinct Post-Transplant T-Cell Clusters Associated with Kidney Allograft Function.Med Sci (Basel)2026https://conductscience.org/library/papers/42201030PubMed
42010035Immunomodulatory Strategies for Managing Viral Infections in Solid Organ Transplantation: Progress and Challenges.Curr Microbiol2026https://conductscience.org/library/papers/42010035PubMed
41671187Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41671187PubMed
41634502Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study.Ann Hematol2026https://conductscience.org/library/papers/41634502PubMed
41393858One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection.Clin Kidney J2025https://conductscience.org/library/papers/41393858PubMed
40444214Targeting CD38 in Antibody-Mediated Rejection.Transpl Int2025https://conductscience.org/library/papers/40444214PubMed
40440205Antibody-mediated rejection-treatment standard.Nephrol Dial Transplant2025https://conductscience.org/library/papers/40440205PubMed
39659965Shedding Light on Microvascular Inflammation: Understanding Outcomes, But What Sparks the Flame?Transpl Int2024https://conductscience.org/library/papers/39659965PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39479216

GET https://conductscience.org/api/papers/v1/39479216/references?page=2